New Weight-Loss Drug Shows Promise in Treating Rare Liver Condition
A groundbreaking trial has found that a key ingredient in blockbuster weight-loss drugs could help manage a serious liver condition before it becomes life-threatening. The study, published in the New England Journal of Medicine, suggests that semaglutide, a GLP-1 receptor agonist, may be a viable treatment for patients with metabolic dysfunction-associated steatohepatitis (MASH). MASH occurs … Read more